Mirella Lazarov

1.3k total citations
12 papers, 838 citations indexed

About

Mirella Lazarov is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mirella Lazarov has authored 12 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mirella Lazarov's work include NF-κB Signaling Pathways (3 papers), Advanced Breast Cancer Therapies (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Mirella Lazarov is often cited by papers focused on NF-κB Signaling Pathways (3 papers), Advanced Breast Cancer Therapies (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Mirella Lazarov collaborates with scholars based in United States, United Kingdom and France. Mirella Lazarov's co-authors include Qun Lin, Yoshiaki Kubo, Ti Cai, Maya Dajee, Shiying Tao, Cheryl L. Green, Paul A. Khavari, M. Peter Marinkovich, Alan J. Russell and Jennifer Zhang and has published in prestigious journals such as Nature, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Mirella Lazarov

11 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirella Lazarov United States 8 442 259 246 194 120 12 838
M Korabiowska Germany 18 471 1.1× 313 1.2× 161 0.7× 149 0.8× 72 0.6× 80 1.1k
Mary E. Zeigler United States 13 427 1.0× 133 0.5× 199 0.8× 169 0.9× 130 1.1× 19 858
Yukihiko Kato Japan 17 764 1.7× 232 0.9× 132 0.5× 161 0.8× 71 0.6× 55 1.2k
Joe M. Angel United States 15 589 1.3× 243 0.9× 144 0.6× 150 0.8× 78 0.7× 34 883
Nobuyasu Komazawa Japan 7 498 1.1× 414 1.6× 155 0.6× 204 1.1× 82 0.7× 7 908
Elizabeth K. Duperret United States 18 474 1.1× 435 1.7× 143 0.6× 476 2.5× 129 1.1× 25 1.1k
Jehng-Kang Wang Taiwan 18 295 0.7× 134 0.5× 208 0.8× 157 0.8× 136 1.1× 40 854
Yuangang Liu United States 15 361 0.8× 189 0.7× 89 0.4× 169 0.9× 64 0.5× 26 651
Masahisa Shindo Japan 8 452 1.0× 200 0.8× 439 1.8× 433 2.2× 76 0.6× 19 942
Christine Wagner Austria 19 497 1.1× 392 1.5× 111 0.5× 391 2.0× 96 0.8× 41 1.0k

Countries citing papers authored by Mirella Lazarov

Since Specialization
Citations

This map shows the geographic impact of Mirella Lazarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirella Lazarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirella Lazarov more than expected).

Fields of papers citing papers by Mirella Lazarov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirella Lazarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirella Lazarov. The network helps show where Mirella Lazarov may publish in the future.

Co-authorship network of co-authors of Mirella Lazarov

This figure shows the co-authorship network connecting the top 25 collaborators of Mirella Lazarov. A scholar is included among the top collaborators of Mirella Lazarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirella Lazarov. Mirella Lazarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Morgensztern, Daniel, Melissa L. Johnson, Charles M. Rudin, et al.. (2020). SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study. Lung Cancer. 145. 126–131. 19 indexed citations
2.
Sharman, Jeff P., Steven Coutré, Richard R. Furman, et al.. (2014). Efficacy of idelalisib in CLL subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial.. Journal of Clinical Oncology. 32(15_suppl). 7011–7011. 8 indexed citations
3.
Yu, Wenjing, Ajay Pandita, Elicia Penuel, et al.. (2011). Exploratory biomarker analyses from OAM4558g: A placebo-controlled phase II study of erlotinib with or without MetMAb in patients with advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 29(15_suppl). 7529–7529. 12 indexed citations
4.
Lazarov, Mirella, et al.. (2010). Periodontal Regeneration Using an Anabolic Peptide With Two Carriers in Baboons. Journal of Periodontology. 81(5). 727–736. 7 indexed citations
5.
Lazarov, Mirella, et al.. (2005). Topical Application of A Novel Immunomodulatory Peptide, RDP58, Reduces Skin Inflammation in the Phorbol Ester-Induced Dermatitis Model. Journal of Investigative Dermatology. 125(3). 473–481. 63 indexed citations
6.
Travis, Simon, et al.. (2005). Rdp58 Is a Novel and Potentially Effective Oral Therapy for Ulcerative Colitis. Inflammatory Bowel Diseases. 11(8). 713–719. 93 indexed citations
7.
Dajee, Maya, Mirella Lazarov, Jennifer Zhang, et al.. (2003). NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 421(6923). 639–643. 448 indexed citations
8.
9.
Lazarov, Mirella, Cheryl L. Green, Jennifer Zhang, et al.. (2003). Escaping G1Restraints on Neoplasia: Cdk4 Regulation by Ras and NF-KappaB. Cell Cycle. 2(2). 78–79. 4 indexed citations
10.
Lazarov, Mirella, Yoshiaki Kubo, Ti Cai, et al.. (2002). CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nature Medicine. 8(10). 1105–1114. 160 indexed citations
11.
Lazarov, Mirella, Mickey M. Martin, Barry M. Willardson, & Terry S. Elton. (2000). Molecular cloning and characterization of the human phosducin-like protein (hPhLP) promoter. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1492(2-3). 460–464.
12.
Lazarov, Mirella, Mickey M. Martin, Barry M. Willardson, & Terry S. Elton. (1999). Human phosducin-like protein (hPhLP) messenger RNA stability is regulated by cis-acting instability elements present in the 3′-untranslated region. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1446(3). 253–264. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Korabiowska Breakdown of academic impact, for papers by Mary E. Zeigler Breakdown of academic impact, for papers by Yukihiko Kato Breakdown of academic impact, for papers by Joe M. Angel Breakdown of academic impact, for papers by Nobuyasu Komazawa Breakdown of academic impact, for papers by Elizabeth K. Duperret Breakdown of academic impact, for papers by Jehng-Kang Wang Breakdown of academic impact, for papers by Yuangang Liu Breakdown of academic impact, for papers by Masahisa Shindo Breakdown of academic impact, for papers by Christine Wagner
Rankless by CCL
2026